Genetic Technologies Provides Update on COVID-19 Disease Severity Test Highlights -Genetic Technologies has filed a provisional patent for its COVID-19 Severity Risk Test with the Patent Office in Australia -The COVID-19 Severity Risk Test comprises a polygenic risk test (PRS) and assessment for clinical risk factors -Genetic Technologies has completed the...
YELLOW BRICK ROAD - MONTHLY WEDGE BREAKOUTS
Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia
After ~2.33 it can go up from the gap/lack of resistance
Short term uptrend channel should hit a maximum around 3.84 before the big news
NASDAQ:GENE is a great value play here.. TIGHT TIGHT $0.15-$0.20 stop loss while it is sitting on the bottom of the channel it has been trading in... with upside of 15:1 profit to risk ratio. I don't look for the upper channel to hit but the midline is a possibility. The next 24 hours will either hit your stop loss or give you a fat profit. :) GO LONG!
Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
GENE - Watching for completion of Ascending Triangle
$GENE like the 200MA break and would like to see it continue up to low $3's
See notes on chart. Widening Bollinger Bands lead to heavy up-moves before a strong pull-back. Look for significant upside before a crash.
Start of a long term, high profit trend. Has continued short interest in the face of reg-sho forced buybacks (buy-ins), brokers are forcing people to cover at a loss and now have the stock on not able to borrow lists. At historically low levels with support and high bullish volume. Reward to risk favors the longs, a wise portfolio investment.